Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database.

Hanseul ChoKyeongmin LeeYi Deun JeongRaphael UdehKrishna Prasad AcharyaJiseung KangLaurent BoyerGuillaume FondHayeon LeeJaeyu ParkHyeon Jin KimJiyoung HwangHui-Jeong HwangDong Keon Yon

Published in: Asian journal of psychiatry (2024)

The associations between CVDs and ADHD medications vary, with amphetamines posing a higher risk, while lisdexamfetamine and methylphenidate exhibit better safety profiles.

Keyphrases

attention deficit hyperactivity disorder
adverse drug
cardiovascular disease
autism spectrum disorder
working memory
healthcare
type diabetes
emergency department
electronic health record
drug induced
cardiovascular events
metabolic syndrome